VALYSTR · Stock research
Listed on NasdaqGM. What the market is pricing into NewAmsterdam Pharma Company N.V. (NAMS) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Pharmaceutical Preparations · market value about $2.4B · revenue $7.1M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows